Significant Ownership of Dauntless Investment Group, LLC
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Dauntless Investment Group, LLC focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/Matthew Okkerse - CFO
- Manager location
- Milford, MI
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Dauntless Investment Group, LLC with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Dauntless Investment Group, LLC
Significant Ownership of Dauntless Investment Group, LLC
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| FEMY | FEMASYS INC | Common | 9.9% | $1,549,149 | +$1,045,272 | 4,395,996 | +207% | Dauntless Investment Group, LLC | 30 Sep 2025 |
| AEON | AEON Biopharma, Inc. | Common | 9.7% | $44,372 | 108,224 | Dauntless Investment Group, LLC | 26 Feb 2025 | ||
| AZTR | Azitra, Inc. | Common Stock | 9.6% | $812,649 | 5,804,636 | Dauntless Investment Group, LLC | 24 Jun 2026 | ||
| OKYO | OKYO Pharma Ltd | Common | 1.2% | $1,466,437 | -$6,066,133 | 471,523 | -81% | Dauntless Investment Group, LLC | 31 Dec 2025 |
| KZIA | KAZIA THERAPEUTICS LTD | American Depository Shares | 0% | 1 | -100% | Dauntless Investment Group, LLC | 31 Dec 2025 |
Schedules 13D/G Reported by Dauntless Investment Group, LLC:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.